ATE216258T1 - Insulin präparationen enthaltend methanol zur pulmonaren verabreichung - Google Patents

Insulin präparationen enthaltend methanol zur pulmonaren verabreichung

Info

Publication number: ATE216258T1
Authority: AT; Austria
Prior art keywords: insulin; formulation; preparations containing; pulmonary administration; containing methanol
Prior art date: 1998-10-16

Application number

AT99948726T

Other languages

English (en)

Inventor

Svend Havelund

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-16

Filing date

1999-10-15

Publication date

2002-05-15

1999-10-15 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2002-05-15 Application granted granted Critical

2002-05-15 Publication of ATE216258T1 publication Critical patent/ATE216258T1/de

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 8
102000004877 Insulin Human genes 0.000 title abstract 4
108090001061 Insulin Proteins 0.000 title abstract 4
229940125396 insulin Drugs 0.000 title abstract 4
230000002685 pulmonary effect Effects 0.000 title abstract 2
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 title 3
238000002360 preparation method Methods 0.000 title 1
238000009472 formulation Methods 0.000 abstract 4
239000000203 mixture Substances 0.000 abstract 4
NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 2
NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 abstract 2
229940041616 menthol Drugs 0.000 abstract 2
101000976075 Homo sapiens Insulin Proteins 0.000 abstract 1
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract 1
150000002500 ions Chemical class 0.000 abstract 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
150000002989 phenols Chemical class 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Immunology (AREA)
Zoology (AREA)
Obesity (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

AT99948726T 1998-10-16 1999-10-15 Insulin präparationen enthaltend methanol zur pulmonaren verabreichung ATE216258T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA199801326		1998-10-16
PCT/DK1999/000557 WO2000023099A1 (en)	1998-10-16	1999-10-15	Insulin preparations for pulmonary delivery containing menthol

Publications (1)

Publication Number	Publication Date
ATE216258T1 true ATE216258T1 (de)	2002-05-15

Family

ID=8103609

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99948726T ATE216258T1 (de)	1998-10-16	1999-10-15	Insulin präparationen enthaltend methanol zur pulmonaren verabreichung

Country Status (20)

Country	Link
EP (1)	EP1121145B1 (de)
JP (1)	JP2002527488A (de)
KR (1)	KR20010080132A (de)
CN (1)	CN1323220A (de)
AT (1)	ATE216258T1 (de)
AU (1)	AU758108B2 (de)
BR (1)	BR9914568A (de)
CA (1)	CA2346884A1 (de)
CZ (1)	CZ20011133A3 (de)
DE (1)	DE69901314T2 (de)
DK (1)	DK1121145T3 (de)
ES (1)	ES2177324T3 (de)
HU (1)	HUP0103606A3 (de)
IL (1)	IL142002A0 (de)
NO (1)	NO20011841L (de)
PL (1)	PL347171A1 (de)
PT (1)	PT1121145E (de)
UA (1)	UA67798C2 (de)
WO (1)	WO2000023099A1 (de)
ZA (1)	ZA200102068B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7089053B1 (en)	1999-10-14	2006-08-08	Pola Chemical Industries Inc	Compositions for drug administration by electroporation
JP4871469B2 (ja) *	1999-10-15	2012-02-08	ポーラ化成工業株式会社	エレクトロポーレーション用の経皮吸収促進剤
DE10114178A1 (de)	2001-03-23	2002-10-10	Aventis Pharma Gmbh	Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de)	2002-06-18	2004-01-15	Aventis Pharma Deutschland Gmbh	Saure Insulinzubereitungen mit verbesserter Stabilität
RS59913B1 (sr)	2008-10-17	2020-03-31	Sanofi Aventis Deutschland	Kombinacija insulina i glp-1-agonista
SG10201403840VA (en)	2009-07-06	2014-10-30	Sanofi Aventis Deutschland	Aqueous insulin preparations containing methionine
PL2498801T3 (pl)	2009-11-13	2018-08-31	Sanofi Aventis Deutschland	Kompozycja farmaceutyczna zawierająca desPro<sup>36</sup>eksendyno-4(1-39)-Lys6-NH2 i metioninę
SI2498802T1 (sl)	2009-11-13	2015-05-29	Sanofi-Aventis Deutschland Gmbh	Farmacevtski sestavek, ki vsebuje agonist GLP-1, inzulin in metionin
BR112013004756B1 (pt)	2010-08-30	2020-04-28	Sanofi Aventis Deutschland	uso de ave0010 para a fabricação de um medicamento para o tratamento da diabetes melito tipo 2
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CA2846413C (en)	2011-08-29	2021-11-02	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
TWI559929B (en)	2011-09-01	2016-12-01	Sanofi Aventis Deutschland	Pharmaceutical composition for use in the treatment of a neurodegenerative disease
TWI758239B (zh)	2014-12-12	2022-03-21	德商賽諾菲阿凡提斯德意志有限公司	甘精胰島素/利司那肽固定比率配製劑
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
GB201906917D0 (en) *	2019-05-16	2019-07-03	Intract Pharma Ltd	Novel compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5506203C1 (en) *	1993-06-24	2001-02-06	Astra Ab	Systemic administration of a therapeutic preparation
US5474978A (en) *	1994-06-16	1995-12-12	Eli Lilly And Company	Insulin analog formulations
US5504188A (en) *	1994-06-16	1996-04-02	Eli Lilly And Company	Preparation of stable zinc insulin analog crystals
US5635161A (en) *	1995-06-07	1997-06-03	Abbott Laboratories	Aerosol drug formulations containing vegetable oils
PL188736B1 (pl) *	1996-06-20	2005-04-29	Novo Nordisk As	Wodny preparat insuliny oraz sposób jego przygotowania
ATE219942T1 (de) *	1997-03-20	2002-07-15	Novo Nordisk As	Therapeutische pulverformulierung zur pulmonaren anwendung, welche kristallines insulin enthält

1999
- 1999-10-15 HU HU0103606A patent/HUP0103606A3/hu unknown
- 1999-10-15 EP EP99948726A patent/EP1121145B1/de not_active Expired - Lifetime
- 1999-10-15 AT AT99948726T patent/ATE216258T1/de not_active IP Right Cessation
- 1999-10-15 CA CA002346884A patent/CA2346884A1/en not_active Abandoned
- 1999-10-15 ES ES99948726T patent/ES2177324T3/es not_active Expired - Lifetime
- 1999-10-15 CN CN99812209A patent/CN1323220A/zh active Pending
- 1999-10-15 UA UA2001042149A patent/UA67798C2/uk unknown
- 1999-10-15 CZ CZ20011133A patent/CZ20011133A3/cs unknown
- 1999-10-15 DK DK99948726T patent/DK1121145T3/da active
- 1999-10-15 BR BR9914568-5A patent/BR9914568A/pt not_active IP Right Cessation
- 1999-10-15 KR KR1020017004638A patent/KR20010080132A/ko not_active Withdrawn
- 1999-10-15 JP JP2000576872A patent/JP2002527488A/ja not_active Withdrawn
- 1999-10-15 AU AU61890/99A patent/AU758108B2/en not_active Ceased
- 1999-10-15 IL IL14200299A patent/IL142002A0/xx unknown
- 1999-10-15 PL PL99347171A patent/PL347171A1/xx unknown
- 1999-10-15 PT PT99948726T patent/PT1121145E/pt unknown
- 1999-10-15 WO PCT/DK1999/000557 patent/WO2000023099A1/en not_active Ceased
- 1999-10-15 DE DE69901314T patent/DE69901314T2/de not_active Expired - Fee Related
2001
- 2001-03-13 ZA ZA200102068A patent/ZA200102068B/en unknown
- 2001-04-10 NO NO20011841A patent/NO20011841L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
PL347171A1 (en)	2002-03-25
CN1323220A (zh)	2001-11-21
AU758108B2 (en)	2003-03-13
KR20010080132A (ko)	2001-08-22
BR9914568A (pt)	2001-07-03
CZ20011133A3 (cs)	2001-08-15
IL142002A0 (en)	2002-03-10
NO20011841L (no)	2001-06-15
DK1121145T3 (da)	2002-08-12
CA2346884A1 (en)	2000-04-27
EP1121145A1 (de)	2001-08-08
JP2002527488A (ja)	2002-08-27
ES2177324T3 (es)	2002-12-01
NO20011841D0 (no)	2001-04-10
PT1121145E (pt)	2002-09-30
ZA200102068B (en)	2001-10-12
EP1121145B1 (de)	2002-04-17
DE69901314T2 (de)	2002-11-21
DE69901314D1 (de)	2002-05-23
UA67798C2 (uk)	2004-07-15
HUP0103606A3 (en)	2002-05-28
AU6189099A (en)	2000-05-08
WO2000023099A1 (en)	2000-04-27
HUP0103606A2 (hu)	2002-02-28

Similar Documents

Publication	Publication Date	Title
DE69901314D1 (de)	2002-05-23	Insulin präparationen enthaltend methanol zur pulmonaren verabreichung
ATE277630T1 (de)	2004-10-15	Stabile konzentrierte insulin präparationen zur pulmonaren verabreichung
CO4410203A1 (es)	1997-01-09	Formulaciones de analogos de insulina
CO5271759A1 (es)	2003-04-30	Formulacion en solucion que contiene una mezcla de disolventes
RU94040387A (ru)	1996-10-20	Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
BR9811249A (pt)	2000-09-05	Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma
BR0012013A (pt)	2002-03-26	Métodos de aerossolizar uma formulação farmacêutica, e de administrar uma formulação farmacêutica, dispositivo de aerossolização, sistema de aerossolização, e, receptáculo
BR9917089A (pt)	2001-10-16	Composições e métodos para distribuição mucosal
CA2416383A1 (en)	2002-01-24	Solution-, dispersion- or emulsion-producing film dermatics
IL140848A (en)	2005-05-17	Pharmaceutical compositions containing phenylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
GEP20022669B (en)	2002-04-25	Pharmaceutical Composition for Application To Mucosa
GEP20043257B (en)	2004-06-25	Aerosol Particles Resistant to Hygrosscopic Growth, Method for Their Production and Use Thereof for Delivering an Active Agent to the Lung of A Human Patient by Inhalation
DK1146896T3 (da)	2002-09-02	Formuleringer, som indeholder monodisperse hexamere acylerede insulin-analoger
PL357132A1 (en)	2004-07-12	Stable, nasally, orally or sublingually applicable pharmaceutical preparation
Morris	1997	Uptake of acetaldehyde vapor and aldehyde dehydrogenase levels in the upper respiratory tracts of the mouse, rat, hamster, and guinea pig
MY136546A (en)	2008-10-31	A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component
ATE268181T1 (de)	2004-06-15	Pharmazeutische zubereitungen enthaltend alginate
Morris et al.	2002	Regional distribution and kinetics of vinyl acetate hydrolysis in the oral cavity of the rat and mouse
JPH11155940A (ja)	1999-06-15	ホルムアルデヒド、ホルマリン除去剤
GEP20032942B (en)	2003-04-25	Stabile Pharmaceutical Compositions Comprising Levosimendan and Alginic Acid
GR1002731B (el)	1997-07-04	Φαρμακευτικα ενεσιμα διαλυματα περιεχοντα συνδυασμους παρακεταμολης με αλλες δραστικες ουσιες.
AU2001258859A1 (en)	2001-12-11	Pralmorelin-containing nasal drop preparations
IT1199619B (it)	1988-12-30	Vernici additivate
UA48425A (uk)	2002-08-15	Спосіб хімічної ексфоліації шкірного покриву
YANG	1996	Construction of Culture and Ethics in Chinese Voluntary Dependence Quit Institution

Legal Events

Date	Code	Title	Description
2002-08-15	UEP	Publication of translation of european patent specification
2005-07-15	REN	Ceased due to non-payment of the annual fee